Alleviative effect of ciliary neurotrophic factor analogue on high fat‐induced hepatic steatosis is partially independent of the central regulation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/1440-1681.12709PMID 27973757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alleviative effect of ciliary neurotrophic factor analogue on high fat‐induced hepatic steatosis is partially independent of the central regulation

  2017cited by this paper
• Action of Administered Ciliary Neurotrophic Factor on the Mouse Dorsal Vagal Complex

  2016cited by this paper
• Fatty liver is an independent predictor of early carotid atherosclerosis.

  2016cited by this paper
• Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease

  2016cited by this paper
• The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter

  2016cited by this paper
• Non-alcoholic fatty liver disease.

  2016cited by this paper
• Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells.

  2015cited by this paper
• Insulin action in the hypothalamus and dorsal vagal complex

  2014cited by this paper
• Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production.

  2012cited by this paper
• Human Fatty Liver Disease: Old Questions and New Insights

  2011cited by this paper
• Therapeutic effects of a recombinant mutant of the human ciliary neurotrophic factor in a mouse model of metabolic syndrome.

  2010cited by this paper
• Activation of N-Methyl-d-aspartate (NMDA) Receptors in the Dorsal Vagal Complex Lowers Glucose Production*

  2010cited by this paper
• Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production

  2008cited by this paper
• Metabolic remodeling in adipocytes promotes ciliary neurotrophic factor-mediated fat loss in obesity.

  2008cited by this paper
• The novel mechanism of recombinant human ciliary neurotrophic factor on the anti-diabetes activity.

  2007cited by this paper
• Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury.

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Increased lipid peroxidation in patients with non‐alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8‐isoprostane

  2006cited by this paper
• Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice.

  2006cited by this paper
• Clinical features associated with improvement of fatty liver disease

  2005cited by this paper
• Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study

  2005cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

  2004cited by this paper
• Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.

  2004cited by this paper
• Ciliary neurotrophic factor and leptin induce distinct patterns of immediate early gene expression in the brain.

  2004cited by this paper
• Activation of the Hypothalamic Arcuate Nucleus Predicts the Anorectic Actions of Ciliary Neurotrophic Factor and Leptin in Intact and Gold Thioglucose‐Lesioned Mice

  2003cited by this paper
• Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

  2003cited by this paper
• Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice

  2003cited by this paper
• Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

  2003cited by this paper
• Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited

  2003cited by this paper
• Non‐alcoholic fatty liver disease

  2002cited by this paper
• Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss

  2002cited by this paper
• Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity

  2001cited by this paper
• Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

  2001cited by this paper
• Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR-α) and PPAR-γ Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR-γ-Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic Mice* * This work was supported by

  2000cited by this paper
• Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.

  2000cited by this paper
• CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

  2000cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis

  1996cited by this paper
• Body fat topography as an independent predictor of fatty liver.

  1993cited by this paper
• Ciliary neurotrophic factor induces acute‐phase protein expression in hepatocytes

  1992cited by this paper
• A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

  1990cited by this paper

• Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease

  2025cites this paper
• Effect of aerobic or resistance exercise, or both on insulin secretion, ciliary neurotrophic factor, and insulin-like growth factor-1 in dieting older adults with obesity.

  2025cites this paper
• Ciliary neurotrophic factor is increased in the plasma of patients with obesity and its levels correlate with diabetes and inflammation indices

  2022cites this paper
• Protective effects of docosahexaenoic acid against non-alcoholic hepatic steatosis through activating of JAK2/STAT3 signaling pathway

  2021cites this paper
• New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology

  2021cites this paper
• Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease

  2020cites this paper
• Immunopathobiology and therapeutic targets related to cytokines in liver diseases

  2020cites this paper
• Biological Effects of Ciliary Neurotrophic Factor on hMADS Adipocytes

  2019cites this paper
• Alleviative effect of ciliary neurotrophic factor analogue on high fat‐induced hepatic steatosis is partially independent of the central regulation

  2017cites this paper
• Psychopharmacognosy: Alcohol Dependence

  2016cites this paper